1033. Unexpected Allies: Vancomycin and Cefazolin Combination Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia

BACKGROUND: Vancomycin (VAN) monotherapy is regarded as first-line treatment of bloodstream infections (BSIs) due to methicillin-resistant Staphylococcus aureus (MRSA). However, in vitro and clinical evidence indicate synergy is achieved against MRSA when certain beta-lactam antibiotics are combined...

Descripción completa

Detalles Bibliográficos
Autores principales: Caniff, Kaylee E, Kunz Coyne, Ashlan J, Rybak, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678159/
http://dx.doi.org/10.1093/ofid/ofad500.064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678159/
http://dx.doi.org/10.1093/ofid/ofad500.064

Ejemplares similares